NS13001 is a selective SK2/3 modulator that acts as a potential therapeutic agent for treatment of SCA2. References: Coleman N, Brown BM, Oliván-Viguera A, Singh V, Olmstead MM, Valero MS, Kohler R, Wulff H. New positive Ca2+-activated K+ channel gating modulators with selectivity for KCa3.1. Mol Pharmacol. 2014 Sep;86(3):342-57. doi: 10.1124/mol.114.093286. Epub 2014 Jun 23. PubMed PMID: 24958817; PubMed Central PMCID: PMC4152908.

纯度：≥98%

CAS：1063331-94-1